Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Adaptive Biotechnologies Corp (NASDAQ: ADPT) closed at $8.33 in the last session, down -2.23% from day before closing price of $8.52. In other words, the price has decreased by -$2.23 from its previous closing price. On the day, 2.0 million shares were traded. ADPT stock price reached its highest trading level at $8.74 during the session, while it also had its lowest trading level at $8.185.
Ratios:
We take a closer look at ADPT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.81 and its Current Ratio is at 2.89. In the meantime, Its Debt-to-Equity ratio is 0.44 whereas as Long-Term Debt/Eq ratio is at 0.39.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 14 ’25 when Chad Robins bought 158,921 shares for $8.33 per share.
Chad Robins bought 100,287 shares of ADPT for $854,445 on Feb 13 ’25. On Nov 18 ’24, another insider, PISKEL KYLE, who serves as the Chief Financial Officer of the company, sold 248 shares for $4.98 each. As a result, the insider received 1,235 and left with 154,330 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 1230957440 and an Enterprise Value of 1231103232. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.87 while its Price-to-Book (P/B) ratio in mrq is 6.08. Its current Enterprise Value per Revenue stands at 6.879 whereas that against EBITDA is -9.079.
Stock Price History:
The Beta on a monthly basis for ADPT is 1.55, which has changed by 1.1636364 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, ADPT has reached a high of $8.56, while it has fallen to a 52-week low of $2.28. The 50-Day Moving Average of the stock is 19.20%, while the 200-Day Moving Average is calculated to be 66.85%.
Shares Statistics:
According to the various share statistics, ADPT traded on average about 1.42M shares per day over the past 3-months and 1653160 shares per day over the past 10 days. A total of 147.77M shares are outstanding, with a floating share count of 142.71M. Insiders hold about 3.30% of the company’s shares, while institutions hold 97.90% stake in the company. Shares short for ADPT as of 1738281600 were 8530375 with a Short Ratio of 6.02, compared to 1735603200 on 9189671. Therefore, it implies a Short% of Shares Outstanding of 8530375 and a Short% of Float of 7.4200004.
